Grenzacherstrasse 124
Basel 4058
Switzerland
41 61 688 11 11
https://www.roche.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - General
Funcionários Integrais: 103.605
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Severin Schwan Ph.D. | Executive Chairman | 7,51M | N/A | 1967 |
Dr. Thomas Schinecker | Chief Executive Officer | 3,87M | N/A | 1975 |
Dr. Alan Hippe | Chief Financial & Information Officer | 4,11M | N/A | 1967 |
Dr. Bruno Eschli | Head of Investor Relations | N/A | N/A | N/A |
Ms. Claudia Bockstiegel | General Counsel | N/A | N/A | 1964 |
Ms. Pascale Schmidt | Chief Compliance Officer | N/A | N/A | 1973 |
Ms. Barbara Schadler | Head of Group Communications | N/A | N/A | 1962 |
Ms. Cristina A. Wilbur | Chief People Officer | 2,92M | N/A | 1967 |
Dr. Nicolas Dunant | Head of Group Media Relations | N/A | N/A | N/A |
Mr. Boris L. Zaitra | Head of Group Business Development and M&A | N/A | N/A | 1972 |
O QualityScore de governança da ISS da Roche Holding AG a partir de 1 de abril de 2024 é 8. As principais pontuações para Auditoria são: 4; Conselho: 6; Direitos de Acionistas: 9; Compensação: 8.